Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study

BACKGROUND: Interleukin-22 (IL-22), recently identified as a crucial parameter of pathology in experimental liver damage, may determine survival in clinical end-stage liver disease. Systematic analysis of serum IL-22 in relation to morbidity and mortality of patients with advanced liver cirrhosis ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kronenberger, Bernd, Rudloff, Ina, Bachmann, Malte, Brunner, Friederike, Kapper, Lisa, Filmann, Natalie, Waidmann, Oliver, Herrmann, Eva, Pfeilschifter, Josef, Zeuzem, Stefan, Piiper, Albrecht, Mühl, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519550/
https://www.ncbi.nlm.nih.gov/pubmed/22967278
http://dx.doi.org/10.1186/1741-7015-10-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519550/
https://www.ncbi.nlm.nih.gov/pubmed/22967278
http://dx.doi.org/10.1186/1741-7015-10-102

Ejemplares similares